Questions about MS? 0808 800 8000
Donate

Capturing the full benefits of DMTs

man injecting dmts into his leg
Lead researcher:
Dr Annie Hawton
Based at:
University of Exeter
MS Society funding:
£159,590
Status:
Active

The cost effectiveness of MS treatments is assessed before they're made available on the NHS, but is it accurate?

About the project

The cost effectiveness of MS treatments is assessed before they're made available on the NHS. The review process isn’t specifically tailored to MS and may not capture the benefits of these treatments, potentially limiting their availability.

What happens in the project?

We want to make the assessment of treatments for people with MS more relevant to the condition. Our researchers will review the tests used to measure cost effectiveness to assess the extent that they reflect the wide variety of symptoms and the full impact that MS has on people’s lives.

How will it help people with MS?

We can use this evidence to improve services for people with MS and to help to increase access to treatments.

The difference you can make

We want everyone with MS to have access to the treatments they need to live well with MS. With your help, we can continue to support vital research like this.

You may also be interested in

How do I pick the right DMT for my relapsing MS?

Our Research Network member Sarah Rees spoke to Dr Ana Manzano and Professor Helen Ford. They discussed designing an online disease modifying therapy (DMT) decision aid to support people with relapsing MS. 

DMTs can reverse MS symptoms for some people

Disease modifying treatments (DMTs) may be able to reverse the symptoms caused by MS for some people with relapsing MS, according to new research published in the Journal of Neurology. This is the first study that has measured whether people’s long-term symptoms improve following treatment.